comparemela.com

Citi Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Here s what Wall Street is saying about Wegovy following Novo Nordisk s key study

Analysts were watching the data given weight-loss drugs have become a major investing and health theme.

United statesCiti baumJames shinTrung huynhEli lilly zepboundAndrew baumAngelica peeblesMark purcellEli lillyPeter verdultRichard vosserNovo nordiskMorgan stanleyAmerican heart associationDeutsche bankWall street

Eli Lilly Is Waiting for Obesity-Drug Approval How Much It Could Be Worth

Eli Lilly’s diabetes drug Mounjaro is expected to be approved to treat obesity in the near future. It could drive sales for more than a decade.

Andrew baumLilly mounjaroJonathan weiss dreamstimeCiti baumEli lillyAdam clarkNovo nordiskArticle normalAgricultural machineryHealthcare life sciencesIndustrial goodsRegulation government policyFinancial performanceSales figuresNew products servicesProduct service approvals

Pfizer Sees Steep 2023 Fall in COVID Sales, Aims to Bolster Pipeline

Pfizer on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products as governments cut orders and work through inventories.

United statesNew jerseyBhanvi satijaManas mishraAndrew baumAlbert bourlaCiti baumEvan seigermanJonathan oatisPfizer incGlobal blood therapeutics incExecutive albert bourlaWall streetMichael ermanCovid 19 vaccineCoronavirus vaccine

Pfizer forecasts steep fall in 2023 sales of COVID products

Pfizer Inc on Tuesday forecasted a bigger than expected drop in sales of its COVID 19 vaccine and treatment for 2023, intensifying investor concerns o.

United statesAndrew baumAlbert bourlaCiti baumPfizer inc onGlobal blood therapeutics incPfizer incExecutive albert bourlaThe peninsula

vimarsana © 2020. All Rights Reserved.